![James Watson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Watson
Directeur/Membre du Conseil chez
SCRIBE THERAPEUTICS INC.
Profil
James D.
Watson is currently Director at Scribe Therapeutics, Inc. since 2025.
Former positions include Managing Director & Head-Private Equity at Burrill LLC, SVP-Corporate Development & Marketing at Incyte Corp., Principal at Eli Lilly & Co., General Manager at Ventro Corp., Chief Business Officer & Senior Vice President at Alvine Pharmaceuticals, Inc., General Manager at Chemdex, Inc., and Principal at Wilkerson Group.
Education includes an MBA from Indiana University and undergraduate studies at the University of Portsmouth.
Postes actifs de James Watson
| Sociétés | Poste | Début |
|---|---|---|
| SCRIBE THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/07/2025 |
Anciens postes connus de James Watson
| Sociétés | Poste | Fin |
|---|---|---|
Burrill LLC
 Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions. | Corporate Officer/Principal | 31/12/2009 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| INCYTE CORPORATION | Sales & Marketing | - |
Alvine Pharmaceuticals, Inc.
 Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Corporate Officer/Principal | - |
Chemdex, Inc.
 Chemdex, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, animal health products | Corporate Officer/Principal | - |
Formation de James Watson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Ventro Corp.
 Ventro Corp. Information Technology ServicesTechnology Services Provides e-commerce solutions. | Technology Services |
Alvine Pharmaceuticals, Inc.
Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Health Technology |
Burrill LLC
Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions. | Finance |
Chemdex, Inc.
Chemdex, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, animal health products | Health Technology |
Wilkerson Group
 Wilkerson Group Medical/Nursing ServicesHealth Services Consulting services to pharmaceutical and medical products industry | Health Services |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Portsmouth
 University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops CRISPR-based genetic medicines to extend healthy lifespan through disease prevention and durable therapeutic interventions | Health Technology |
